CS
PRTA icon

Credit Suisse’s Prothena Corp PRTA Stock Holding History

Credit Suisse’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.49M Buy
60,202
+898
+2% +$26.7K ﹤0.01% 2036
2023
Q4 		$2.16M Buy
59,304
+7,553
+15% +$291K ﹤0.01% 1833
2023
Q3 		$2.5M Sell
51,751
-5,646
-10% -$335K ﹤0.01% 1691
2023
Q2 		$3.92M Buy
57,397
+15,682
+38% +$1.01M ﹤0.01% 1493
2023
Q1 		$2.02M Buy
41,715
+2,828
+7% +$149K ﹤0.01% 1860
2022
Q4 		$2.34M Buy
38,887
+7,609
+24% +$446K ﹤0.01% 1777
2022
Q3 		$1.9M Buy
31,278
+3,554
+13% +$112K ﹤0.01% 1889
2022
Q2 		$753K Buy
27,724
+369
+1% +$10.8K ﹤0.01% 2575
2022
Q1 		$1M Buy
27,355
+3,783
+16% +$136K ﹤0.01% 2546
2021
Q4 		$1.17M Sell
23,572
-1,660
-7% -$92K ﹤0.01% 3199
2021
Q3 		$1.8M Buy
25,232
+2,803
+12% +$174K ﹤0.01% 2894
2021
Q2 		$1.15M Buy
22,429
+2,974
+15% +$92.8K ﹤0.01% 3281
2021
Q1 		$488K Sell
19,455
-16,428
-46% -$309K ﹤0.01% 3783
2020
Q4 		$430K Sell
35,883
-9,663
-21% -$114K ﹤0.01% 3867
2020
Q3 		$455K Sell
45,546
-7,477
-14% -$90K ﹤0.01% 3445
2020
Q2 		$555K Buy
53,023
+26,352
+99% +$293K ﹤0.01% 3256
2020
Q1 		$285K Sell
26,671
-758
-3% -$9.18K ﹤0.01% 3454
2019
Q4 		$434K Sell
27,429
-1,533
-5% -$16.4K ﹤0.01% 3649
2019
Q3 		$227K Buy
28,962
+3,271
+13% +$29.1K ﹤0.01% 3820
2019
Q2 		$271K Sell
25,691
-714
-3% -$7.33K ﹤0.01% 3728
2019
Q1 		$321K Sell
26,405
-8,738
-25% -$109K ﹤0.01% 3566
2018
Q4 		$362K Buy
35,143
+4,852
+16% +$57.7K ﹤0.01% 3426
2018
Q3 		$396K Sell
30,291
-10,487
-26% -$151K ﹤0.01% 3413
2018
Q2 		$595K Sell
40,778
-10,675
-21% -$211K ﹤0.01% 3334
2018
Q1 		$1.89M Buy
51,453
+2,367
+5% +$86.1K ﹤0.01% 2471
2017
Q4 		$1.84M Sell
49,086
-94,526
-66% -$4.81M ﹤0.01% 2497
2017
Q3 		$9.3M Buy
143,612
+18,703
+15% +$1.15M 0.01% 1296
2017
Q2 		$6.76M Sell
124,909
-22,824
-15% -$1.22M 0.01% 1430
2017
Q1 		$8.24M Buy
147,733
+19,789
+15% +$1.04M 0.01% 1321
2016
Q4 		$6.29M Buy
127,944
+14,793
+13% +$816K 0.01% 1493
2016
Q3 		$6.79M Sell
113,151
-12,658
-10% -$679K 0.01% 1436
2016
Q2 		$4.4M Buy
125,809
+1,779
+1% +$77.5K ﹤0.01% 1721
2016
Q1 		$5.11M Buy
124,030
+3,164
+3% +$124K 0.01% 1514
2015
Q4 		$8.23M Buy
120,866
+6,019
+5% +$363K 0.01% 1274
2015
Q3 		$5.21M Sell
114,847
-39,781
-26% -$2.32M 0.01% 1536
2015
Q2 		$8.14M Buy
154,628
+26,562
+21% +$1.05M 0.01% 1393
2015
Q1 		$4.88M Buy
128,066
+62,883
+96% +$1.61M ﹤0.01% 1687
2014
Q4 		$1.35M Buy
65,183
+8,481
+15% +$177K ﹤0.01% 2881
2014
Q3 		$1.26M Sell
56,702
-26,957
-32% -$571K ﹤0.01% 2860
2014
Q2 		$1.89M Buy
83,659
+57,362
+218% +$1.43M ﹤0.01% 2773
2014
Q1 		$1.01M Buy
26,297
+5,469
+26% +$176K ﹤0.01% 3113
2013
Q4 		$552K Buy
+20,828
New +$522K ﹤0.01% 3712

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Credit Suisse's PRTA Position: Q1 2024 in Review

Credit Suisse increased its Prothena Corp (PRTA) stake by 1.5% in Q1 2024, buying an estimated $26.7K and bringing the position to 60,202 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2036.

Credit Suisse first reported a position in PRTA in Q4 2013 and has held it in 42 quarters since. The position peaked at $9.3M in Q3 2017. 169 funds tracked by Wall St. Rank hold PRTA as of Q1 2024.

  • Credit Suisse held 60,202 shares of Prothena Corp worth $1.49M as of Q1 2024.
  • Credit Suisse bought 898 Prothena Corp shares in Q1 2024, an estimated $26.7K.
  • Prothena Corp made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2036 holding.
  • Credit Suisse first reported a position in Prothena Corp in Q4 2013 and has held it in 42 quarters since.
  • Credit Suisse's Prothena Corp position peaked at $9.3M in Q3 2017.
  • 169 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.